DiscoverBulls N' Bears with Matt BirneyClarity Pharmaceuticals: From $1 to $9 a share - Could this eventually be a cure for prostate cancer?
Clarity Pharmaceuticals: From $1 to $9 a share - Could this eventually be a cure for prostate cancer?

Clarity Pharmaceuticals: From $1 to $9 a share - Could this eventually be a cure for prostate cancer?

Update: 2024-10-17
Share

Description

Clarity Pharmaceuticals: From $1 to $9 a share - Could this eventually be a cure for prostate cancer? 

Listen to ASX-listed Clarity Pharmaceuticals Executive Chair Alan Taylor talk to Matt Birney on the Bulls N’ Bears Report about Clarity’s amazing clinical trial results that saw a complete response in one patient and lots with a 90 per cent plus reduction in signs of prostate cancer using “copper” based radiopharmaceuticals.

See omnystudio.com/listener for privacy information.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Clarity Pharmaceuticals: From $1 to $9 a share - Could this eventually be a cure for prostate cancer?

Clarity Pharmaceuticals: From $1 to $9 a share - Could this eventually be a cure for prostate cancer?

Bulls N' Bears on 6PR Radio